Cresemba (isavuconazonium sulfate) capsules — Medica
Esophageal candidiasis (systemic) in a patient with human immunodeficiency virus infection – treatment
Initial criteria
- Approve for treatment of esophageal candidiasis in a patient with human immunodeficiency virus infection.
Approval duration
3 months